A detailed history of Vanguard Group Inc transactions in Zynex Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,187,089 shares of ZYXI stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,187,089
Previous 1,180,992 0.52%
Holding current value
$11.1 Million
Previous $12.9 Million 14.17%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$9.86 - $13.74 $60,116 - $83,772
6,097 Added 0.52%
1,187,089 $14.7 Million
Q4 2023

Feb 14, 2024

SELL
$7.1 - $10.89 $111,413 - $170,885
-15,692 Reduced 1.31%
1,180,992 $12.9 Million
Q3 2023

Nov 14, 2023

SELL
$6.95 - $9.89 $2.41 Million - $3.42 Million
-346,231 Reduced 22.44%
1,196,684 $9.57 Million
Q2 2023

Aug 14, 2023

SELL
$8.59 - $14.56 $125,267 - $212,328
-14,583 Reduced 0.94%
1,542,915 $14.8 Million
Q1 2023

May 15, 2023

BUY
$9.53 - $16.8 $961,986 - $1.7 Million
100,943 Added 6.93%
1,557,498 $18.7 Million
Q4 2022

Feb 10, 2023

BUY
$8.71 - $14.28 $502,114 - $823,213
57,648 Added 4.12%
1,456,555 $20.3 Million
Q3 2022

Nov 14, 2022

SELL
$7.19 - $9.91 $857,687 - $1.18 Million
-119,289 Reduced 7.86%
1,398,907 $12.7 Million
Q2 2022

Aug 12, 2022

BUY
$5.78 - $8.87 $597,322 - $916,652
103,343 Added 7.3%
1,518,196 $12.1 Million
Q1 2022

May 13, 2022

BUY
$5.14 - $9.35 $537,006 - $976,850
104,476 Added 7.97%
1,414,853 $8.82 Million
Q4 2021

Feb 14, 2022

SELL
$8.71 - $13.77 $237,922 - $376,141
-27,316 Reduced 2.04%
1,310,377 $13.1 Million
Q3 2021

Nov 12, 2021

BUY
$10.35 - $15.65 $109,699 - $165,874
10,599 Added 0.8%
1,337,693 $15.2 Million
Q2 2021

Aug 13, 2021

BUY
$12.25 - $14.87 $16.3 Million - $19.7 Million
1,327,094 New
1,327,094 $20.6 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $349M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.